PINX: BMXMF
- Last Close 95.88
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style Mid Growth
- Day Range 95.88 – 95.88
- Year Range 78.06 – 110.00
- Market Cap 11.3257 Bil
- Volume / Avg 655.0 / 91.5
- Price / Sales 2.94
- Price / Book 2.89
- Forward Div Yield 0.93%
- Trailing Div Yield 0.89%
Morningstar‘s Stock Analysis BMXMF
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile BMXMF
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of BMXMF’s competitive advantage.
BioMerieux SA
PINX: BMXMF
| Becton Dickinson & Co
XNYS: BDX
| Bio-Techne Corp
XNAS: TECH
| Thermo Fisher Scientific Inc
XNYS: TMO
| |
Price
| 95.88 | 258.53 | 68.07 | 506.17 |
Currency
| USD | USD | USD | USD |
Change
| −$0.14 (0.14%) | −$4.21 (1.60%) | +$0.05 (0.07%) | +$3.15 (0.63%) |
Market Cap
| 11.33 Bil | 75.00 Bil | 10.77 Bil | 195.36 Bil |
Industry
| Diagnostics & Research | Medical Instruments & Supplies | Biotechnology | Diagnostics & Research |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for BioMerieux SA Stock
Yes. BMXMF has a forward dividend yield of 1.02%.
See
BMXMF’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
BMXMF’s market cap is 11.33 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
BMXMF’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
BMXMF’s price/sales is 2.94.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
BMXMF’s price/forward earnings is 28.19.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
BMXMF’s price/book is 2.89.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See BMXMF’s valuation ratios compared to the Market Index.
BMXMF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare BMXMF’s historical performance against its industry peers and the overall market.